122 related articles for article (PubMed ID: 10077015)
41. Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Blazak WF; Brown GL; Gray TJ; Treinen KA; Denny KH
Fundam Appl Toxicol; 1996 Sep; 33(1):11-5. PubMed ID: 8812204
[TBL] [Abstract][Full Text] [Related]
42. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR.
Schmidt PP; Toft KG; Skotland T; Andersson K
J Biol Inorg Chem; 2002 Mar; 7(3):241-8. PubMed ID: 11935348
[TBL] [Abstract][Full Text] [Related]
43. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs.
Toft KG; Hustvedt SO; Grant D; Friisk GA; Skotland T
Eur J Drug Metab Pharmacokinet; 1997; 22(1):65-72. PubMed ID: 9179562
[TBL] [Abstract][Full Text] [Related]
44. MRI of acute myocardial ischemia: comparing a new contrast agent, Gd-DTPA-24-cascade-polymer, with Gd-DTPA.
Roberts HC; Saeed M; Roberts TP; Mühler A; Brasch RC
J Magn Reson Imaging; 1999 Feb; 9(2):204-8. PubMed ID: 10077014
[TBL] [Abstract][Full Text] [Related]
45. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood.
Toft KG; Kindberg GM; Skotland T
J Pharm Biomed Anal; 1997 Apr; 15(7):983-8. PubMed ID: 9160265
[TBL] [Abstract][Full Text] [Related]
46. Dual effects of gadodiamide injection in depiction of the region of myocardial ischemia.
Saeed M; Wendland MF; Yu KK; Li HT; Higgins CB
J Magn Reson Imaging; 1993; 3(1):21-9. PubMed ID: 8428089
[TBL] [Abstract][Full Text] [Related]
47. Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats.
Nelson RC; Chezmar JL; Newberry LB; Malko JA; Gedgaudas-McClees RK; Bernardino ME
Invest Radiol; 1991 Jun; 26(6):569-73. PubMed ID: 1907259
[TBL] [Abstract][Full Text] [Related]
48. Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Skjold A; Amundsen BH; Wiseth R; Støylen A; Haraldseth O; Larsson HB; Jynge P
J Magn Reson Imaging; 2007 Sep; 26(3):720-7. PubMed ID: 17729351
[TBL] [Abstract][Full Text] [Related]
49. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging.
Saeed M; Wagner S; Wendland MF; Derugin N; Finkbeiner WE; Higgins CB
Radiology; 1989 Jul; 172(1):59-64. PubMed ID: 2500678
[TBL] [Abstract][Full Text] [Related]
50. Delineation of acute myocardial infarction with dysprosium DTPA-BMA: influence of dose of magnetic susceptibility contrast medium.
Saeed M; Wendland MF; Yu KK; Higgins CB
J Am Coll Cardiol; 1992 Dec; 20(7):1634-41. PubMed ID: 1452938
[TBL] [Abstract][Full Text] [Related]
51. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
[TBL] [Abstract][Full Text] [Related]
52. MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion.
Thorstensen O; Isberg B; Jorulf H; Westman L; Svahn U; Venizelos N
Acta Radiol; 1997 Jul; 38(4 Pt 2):717-23. PubMed ID: 9245967
[TBL] [Abstract][Full Text] [Related]
53. Metabolism and pharmacokinetics of MnDPDP in man.
Toft KG; Hustvedt SO; Grant D; Martinsen I; Gordon PB; Friisk GA; Korsmo AJ; Skotland T
Acta Radiol; 1997 Jul; 38(4 Pt 2):677-89. PubMed ID: 9245963
[TBL] [Abstract][Full Text] [Related]
54. Multislice measurement of first-pass transit of gadobenate dimeglumine in normal and ischemic myocardium in dogs.
Sakuma H; Wendland MF; Saeed M; Derugin N; Geschwind JF; Lauerna K; Mintorovitch J; Cavagna FM; Higgins CB
Acad Radiol; 1995 Oct; 2(10):864-70. PubMed ID: 9419652
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of myocardial ischemia with echo planar magnetic resonance imaging (EPI): normal and ischemic heart].
Inoue T; Watanabe S; Masuda Y
Nihon Rinsho; 1997 Jul; 55(7):1822-7. PubMed ID: 9233034
[TBL] [Abstract][Full Text] [Related]
56. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
[TBL] [Abstract][Full Text] [Related]
57. Physicochemical characterisation of mangafodipir trisodium.
Tirkkonen B; Aukrust A; Couture E; Grace D; Haile Y; Holm KM; Hope H; Larsen A; Lunde HS; Sjøgren CE
Acta Radiol; 1997 Jul; 38(4 Pt 2):780-9. PubMed ID: 9245974
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging after arterial portography with manganese dipyridoxal diphosphate.
Nelson RC; Chezmar JL; Thompson GH; Webber JB; Garrison MH; Spencer HB; Dillehay DL
Invest Radiol; 1993 Apr; 28(4):335-40. PubMed ID: 8478175
[TBL] [Abstract][Full Text] [Related]
59. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
[TBL] [Abstract][Full Text] [Related]
60. [Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Guo T; Zhang XL; Chang RM; Zhang YZ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):946-8. PubMed ID: 13129729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
